Cupid Secures Rs. 16.23 Crore Orders For Male Condoms From Central Medical Services Society

Cupid Limited, a leading manufacturer, has garnered orders totalling Rs. 16.23 crores from the Central Medical Services Society (CMSS) for the supply of male condoms, the company informed in a press statement on Monday. Established as a Central Procurement Agency (CPA) with Cabinet approval, CMSS plays a crucial role in streamlining drug procurement and distribution for the Department of Health & Family Welfare (DoHFW), under the Ministry of Health and Family Welfare, Government of India.

Cupid successfully secured two separate orders for male condoms from CMSS, amounting to Rs. 9.65 crores and Rs. 6.58 crores, respectively. The company aims to fulfil these orders by April 2024, as disclosed in the exchange filing on January 8, 2024.

Aditya Halwasiya, Managing Director of Cupid , expressed excitement about this significant allocation from the Government of India, highlighting the company’s unwavering commitment to supporting the government’s vision of promoting a safe and healthy lifestyle for all citizens. He stated, “This collaboration underscores the importance of ensuring access to vital resources for the well-being of the community at large.”

Furthermore, Halwasiya emphasised Cupid Limited’s alignment with the Government of India’s initiative to “Help India Play Safe.” He mentioned that Cupid Limited’s proposed production capacity expansion in the next 18-24 months positions the company well for future orders from the government.

This development not only strengthens Cupid Limited’s partnership with the Government of India but also reflects the company’s dedication to contributing to public health initiatives. The successful execution of these orders is anticipated to play a vital role in advancing the accessibility of essential resources within the healthcare sector.

Related Posts

  • Pharma
  • March 18, 2025
  • 99 views
SMS Hospital revamps blood safety protocols after fatal transfusion error

Jaipur: In the wake of a tragic fatality caused by an erroneous blood transfusion at SMS Hospital in Feb 2024, the institution has overhauled its transfusion safety measures. The Immunohematology…

  • Pharma
  • March 18, 2025
  • 101 views
IIT Roorkee researchers discover potential drug to treat Chikungunya and other mosquito-borne diseases

Indian Institute of Technology (IIT) Roorkee scientists have discovered a potential drug that can possibly be used to treat Chikungunya, a mosquito-borne viral disease that causes fever, joint pain, muscle…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

SMS Hospital revamps blood safety protocols after fatal transfusion error

SMS Hospital revamps blood safety protocols after fatal transfusion error

IIT Roorkee researchers discover potential drug to treat Chikungunya and other mosquito-borne diseases

IIT Roorkee researchers discover potential drug to treat Chikungunya and other mosquito-borne diseases

Sun Pharma, Zydus recall products in US

Sun Pharma, Zydus recall products in US

Strides Pharma gains 3% as Singapore arm acquires 100% stake in Amexel Pte

Strides Pharma gains 3% as Singapore arm acquires 100% stake in Amexel Pte

Licensing delays pushing medical device makers abroad: Parliament panel

Licensing delays pushing medical device makers abroad: Parliament panel

1471 drugs samples manufactured in HP failed quality tests in past two years

1471 drugs samples manufactured in HP failed quality tests in past two years